Possible association between serum GB virus C RNA level and disease activity in fulminant hepatitis type G

Journal of Hepatology

Volumn 30, Issue 5, 1999, Pages 801-806

  Inoue, Kazuaki ^a,b   Yoshiba, Makoto ^a   Sekiyama, Kazuhiko ^a   Kohara, Michinori ^b  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Fulminant hepatitis; GB virus C; Real time detection PCR (RTD PCR); Taq Man chemistry

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS; HEPATITIS G VIRUS; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS ISOLATION;

EID: 0033062806     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80132-9     Document Type: Article

References (22)

1. Suzuki H. Viral hepatitis in Japan. Nishioka K, Suzuki H, Mishiro S, Oda T, . Viral Hepatitis and Liver Disease. 1994;426-428 Springer-Verlag, Tokyo.
2. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1:1995;564-569.
3. Linnen J, Wages Jr J, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus; a transfusion transmissible agent. Science. 271:1996;505-508.
4. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 346:1995;1131-1132.
5. Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan? Lancet. 347:1996;908.
6. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet. 347:1996;1552.
7. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Boker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet. 348:1996;1626-1629.
8. Liviak KJ, Flood JA, Marmaro J, Giusti W, Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Method Appl. 4:1995;357-362.
9. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KY, et al. Hepatitis E virus: molecular cloning and sequencing of the full-length viral genome. Virology. 185:1991;120-131.
10. Takahashi Y, Shimizu M. Hepatitis, and the Study Group of Fulminant Hepatitis. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicentre study. J Gastroenterol Hepatol. 6:1991;159-164.
11. Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 20:1996;1169-1172.
12. Bukh J, Kim JP, Govindarajan S, Apgar CL, Foung SKH, Wages J Jr, et al. Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus. J Infect Dis. 177:1998;855-862.
13. Forster V Th. Zwischenmolekulare Energie-wanderung und Fluoreszeng. Ann Phys. 2:1948;55-75.
14. Yoshiba M, Inoue K, Sekiyama K. Hepatitis GB virus C. N Engl J Med. 335:1996;1392-1393.
15. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JWK, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med. 336:1997;747-754.
16. Alter HJ. The cloning and clinical implication of HGV and HGBV-C. N Engl J Med. 334:1996;1536-1537.
17. Berg T, Dirala U, Naumann U, Heuft HG, Kuthner S, Lobeck H, et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfection with hepatitis G virus. J Hepatol. 25:1996;763-768.
18. Schmidt B, Korn K, Fleckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet. 347:1996;909.
19. Pawlotsky JM, Thoraval FR, Muerhoff AS, Pellerin M, Germanidis G, Desai SM, et al. GB virus C infection in patients with chronic hepatitis C. J Med Virol. 54:1998;26-37.
20. Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-α in patients with chronic hepatitis C. Ann Intern Med. 126:1997;874-881.
21. Orito E, Mizokami M, Yasuda K, Sugihara K, Nakamura M, Mukaide M, et al. Interferon-α therapy in patients dually infected with hepatitis C virus and GB virus C/hepatitis G virusvirological response of HGV and pretreatment HGV viremia level. J Hepatol. 27:1997;603-612.
22. Oshita M, Hayashi N, Mita E, Iino S, Hiramatsu N, Hijioka T, et al. GBV-C/HGV infection in chronic hepatitis C. J Med Virol. 55:1998;98-102.